| Agilent–JPMorgan Chase: investor conference, 202601 supply service Agilent presents at JP Morgan Healthcare Conference 2026 |
2026-01-13 |
| Danaher–JPMorgan Chase: investor conference, 202601 supply service Danaher presents at JP Morgan Healthcare Conference 2026 |
2026-01-13 |
| PathoQuest–Charles River: investment, 202601– acquisition of PathoQuest by Charles River SIGNED |
2026-01-12 |
| TOFwerk–Bruker: investment, 202601 acquisition of remaining 60% ownership stake €na by Bruker |
2026-01-08 |
| Exact Sciences–Abbott: investment, 202511– acquisition $21b via cash tender offer at $105/share ANNOUNCED |
2025-11-20 |
| ACD/Labs–Revvity: investment, 202511– acquisition of ACD/Labs by Revvity definitive agreement announced |
2025-11-10 |
| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Repligen–Bank of America: investor conference, 202509 supply service Repligen to present at BofA Global Healthcare Conference London 2025 |
2025-09-25 |
| Repligen–Deutsche Bank: investor conference, 202509 supply service Repligen to present at Deutsche Bank Healthcare Summit 2025 |
2025-09-10 |
| Nautilus Biotechnology–Morgan Stanley: investor conference, 202509 supply service Nautilus to participate in MS Global Healthcare Conference |
2025-09-08 |
| Repligen–Wells Fargo: investor conference, 202509 supply service Repligen to present at Wells Fargo Healthcare Conference 2025 |
2025-09-04 |
| Dash Bio–Aligned Fund: investment, 202507 financing round totalling $11m incl lead investor The Aligned Fund |
2025-07-23 |
| Dash Bio–Cybernetix Ventures: investment, 202507 financing round totalling $11m incl co-investor Cybernetix Ventures |
2025-07-23 |
| Dash Bio–Drive Capital: investment, 202507 financing round totalling $11m incl co-investor Drive Capital |
2025-07-23 |
| Dash Bio–Freestyle Capital: investment, 202507 financing round totalling $11m incl co-investor Freestyle Capital |
2025-07-23 |
| Dash Bio–LifeX Ventures: investment, 202507 financing round totalling $11m incl co-investor LifeX Ventures |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Dash Bio–Swift Ventures: investment, 202507 financing round totalling $11m incl co-investor Swift Ventures |
2025-07-23 |
| Becton Dickinson–Waters: investment, 202507– merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
| Synexa Life Sciences–Waters: mass spectrometer, 202506 supply + collab as one of first customers for new Xevo TQ Absolute XR mass spectrometer |
2025-06-10 |
| Agilent–Leucadia: investor conference, 202506 supply service Agilent participates in Jefferies Global Healthcare Conference in NY |
2025-06-04 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Halo Labs–Waters: investment, 202505 acquisiton of Halo Labs by Waters |
2025-05-21 |
| Bruker–Siscapa: MS-based proteomics, 2020505– collab strategic Biognosys beomces preferred service provider for Siscapa tech to biopharma customers |
2025-05-19 |
| PeptiSystems–Asahi Kasei: peptide synthesis, 202505– collab ww excl integration of Thesys ACS Ergo synthesis column of AKBA into PeptiPro platform |
2025-05-15 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Recipe–Bruker: investment, 202504 majority investment €na by Bruker in Recipe Chemicals + Instruments GmbH |
2025-04-16 |
| Ridom–Bruker: investment, 202504 majority investment €na by Bruker in Ridom GmbH |
2025-04-11 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| Mobilion–ICR: public relations, 202502 service existent ICR Healthcare is media contact |
2025-02-13 |
| Mobilion–Scott Partnership: public relations, 202505 service existent Scott PR is media contact |
2025-02-13 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Owlstone–Gates Foundation: grant, 202404– initial $1.5m grant to develop breat-based diagnostics for developing countries from Gates Foundation |
2025-01-15 |
| Agilent–JPMorgan Chase: investor conference, 202501 supply service Agilent presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Mérieux–JPMorgan Chase: investor conference, 202501 supply service bioMérieux presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Bruker–JPMorgan Chase: investor conference, 202501 supply service Bruker presents at JP Morgan Healthcare Conference 2025 |
2025-01-13 |
| Akoya Biosciences–Quanterix: investment, 202501– merger acquisition with former Quanterix shareholders owning 70% ANNOUNCED |
2025-01-10 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| Tagomics–Agilent: genomic technology, 202411– collab co-marketing agreem of Interlace multiomics services using Agilent genomic profiling products |
2024-11-20 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| PrognomiQ–aMoon: investment, 202411 financing round Series D totalling $34m incl existing + co-investor aMoon |
2024-11-05 |
| PrognomiQ–Bruker: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Bruker |
2024-11-05 |
| PrognomiQ–Catalio Capital: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Catalio Capital Management |
2024-11-05 |
| PrognomiQ–Invus Group: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Invus |
2024-11-05 |
| PrognomiQ–OTHER: investment, 202411 financing round Series D totalling $34m incl new large strategic diagnostics investor |
2024-11-05 |
| PrognomiQ–SEVERAL: investment, 202411 financing round Series D $34m led by Seer Inc |
2024-11-05 |
| Danaher–Ion Opticks: liquid chromatography, 202410– collab co-marketing of Aurora Series XS LC columns with ZenoTOF line MS systems of Sciex |
2024-10-25 |
| Dash Bio–SEVERAL: investment, 202410 seed financing round $6.5m led by Freestyle Capital |
2024-10-24 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| Virscidian–Dotmatics: investment, 202409 acquisition of Virscidian by Dotmatics |
2024-09-25 |
| Bruker–Morgan Stanley: investor conference, 202409 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY |
2024-09-06 |
| Bruker–Wells Fargo: investor conference, 202409 supply service Bruker presents at Wells Fargo Healthcare Conference in Boston |
2024-09-04 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Standard BioTools–UBS: investor conference, 202408 supply service Standard BioTech participates in UBS Genomic Medicine Summit |
2024-08-14 |
| Allogene Therapeutics–Baird: investor conference, 202408 supply service Allogene participates in Baird 2024 Global Healthcare Conference |
2024-08-13 |
| Allogene Therapeutics–Canaccord Genuity: investor conference, 202408 supply service Allogene participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Standard BioTools–Canaccord Genuity: investor conference, 202408 supply service Standard BioTech participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
| EasyPanel–Dotmatics: investment, 202407 acquisition of EasyPanel by Dotmatics |
2024-07-30 |
| Agilent–Sigsense Technologies: lab management software, 202407 supply existent Sigsense technology available via Agilent CrossLab Connect |
2024-07-29 |
| Sigsense Technologies–Agilent: investment, 202407 acquisition €na of Sigsense by Agilent |
2024-07-29 |
| Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital |
2024-07-22 |
| CytoReason–Thermo Fisher: investment, 202407 financing round totalling $80m incl investor Thermo Fisher Scientific |
2024-07-17 |
| Sartorius–Nvidia: AI-based drug discovery + manufacturing, 202405– collab expansion incl adaption of Nvidia Clara Suite + DGX platform |
2024-05-16 |
| Owlstone–Gates Foundation: investment, 202501 financing round Series E first closing totalling $27m incl $5m from new + co-investor Gates Foundation |
2024-04-25 |
| NanoString–Bruker: investment, 202404– acquisition $392.6m of substantially all assets winning bid under Bankruptcy Code |
2024-04-17 |
| NanoString–Patient Square Capital: investment, 202403–202404 stalking horse bid $220m for assets under Bankruptcy Code NOT REALISED |
2024-03-10 |
| Waters–Plasmion: ionisation technology, 202402– collab co-marketing/promotion of SICRIT ion source with Waters Acquity QDa + Select Series Cycli IMS |
2024-02-21 |
| Enable Medicine–KKH Advisors: public relations, 202402 service existent by KKH Advisors |
2024-02-13 |
| Chemspeed–Bruker: investment, 202401– acquisition €na of Chemspeed Technology AG by Bruker |
2024-01-25 |
| Agilent–JPMorgan Chase: investor conference, 202401 supply service Agilent presents at JP Morgan Healthcare Conference 2024 |
2024-01-09 |
| Bruker–JPMorgan Chase: investor conference, 202401 supply service Bruker presents at JP Morgan Healthcare Conference 2024 |
2024-01-08 |
| M-Star–Dotmatics: investment, 202401 acquisition of M-Star by Dotmatics |
2024-01-04 |
| Nion–Bruker: investment, 202401 acquisition $23m of Nion by Bruker |
2024-01-03 |
| LumiraDx–Roche: investment, 202312– acquisition $295m + $55m milestones of parts of LumiraDx Group related to innovative PoC technology |
2023-12-29 |
| Tome Biosciences–SEVERAL: investment, 202312 financing rounds Series A + B $213m announced at launch |
2023-12-12 |
| Olink–Thermo Fisher: investment, 202310– acquisition cash tender offer $3.1b at $26/share by Thermo Fisher |
2023-10-17 |
| SomaLogic–Standard BioTools: investment, 202310–202401 reverse merger with former SomaCare shareholders owning 57% of combined company |
2023-10-04 |
| Agilent–Exact Sciences: investment, 202309– acquisition €na of Resolution Bioscience by Exact Sciences from Agilent |
2023-09-12 |
| Abcam–Danaher: investment, 202308– acquisition $24/share in cash = enterprise value $5.7b incl assumed indebtedness + net of acquired cash |
2023-08-28 |
| PhenomeX–Bruker: investment, 202308–202310 acquisition cash tender offer $108m by Bruker at $1/share |
2023-08-17 |
| NuChem Sciences–Sygnature Discovery: investment, acquisition of NuChem Sciences by Sygnature Discovery |
2023-07-31 |
| Revvity–Scitara: lab informatics, 202307– collab expansion product integration of Signals Software Suite with DLX technology |
2023-07-27 |
| Tome Biosciences–Bruker: investment, 202312 financing rounds Series A + B totalling $213m incl $10m from investor Bruker Corp 7/23 |
2023-07-26 |
| Orange Science–Organomation: sample evaporators, 202307– distribution of nitrogen blowdown evaporator lines of Organimation in JP by Orange Science |
2023-07-20 |
| Interherence–Bruker: investment, 202307 acquisition $17.3m of Interherence GmbH by Bruker |
2023-07-03 |
| Lunaphore–Bio-Techne: investment, 202306–202307 acquisition $170.1m of Lunaphore by Bio-Techne |
2023-06-22 |
| Bruker–Leucadia: investor conference, 202306 supply service Brukers presents at Jefferies 2023 Healthcare Conference |
2023-06-09 |
| Akoya Biosciences–SEVERAL: investment, 202306 public offering up to $43.5m+$6.525m with 8.7m+1.305m shares common stock at $5/share |
2023-06-08 |
| Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform |
2023-06-05 |
| Midwest Biosolutions–Bionter: analytical instruments, 202305– collab Midwest Bio to promote + sell Bionter products + services in the US |
2023-05-08 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
